Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-25
2008-12-30
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S123000
Reexamination Certificate
active
07470706
ABSTRACT:
The invention relates to cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof.The invention relates to compounds of the formula Iin which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
REFERENCES:
patent: 5891878 (1999-04-01), Beasley et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick
patent: 6245744 (2001-06-01), Frick
patent: 6342512 (2002-01-01), Kirsch
patent: 6624185 (2003-09-01), Glombik
patent: 0 462 884 (1993-06-01), None
patent: 52033694 (1977-03-01), None
patent: 54112877 (1979-09-01), None
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 03/074532 (2003-09-01), None
patent: WO 03/097564 (2003-11-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface 7 p. 41.
John F. Hartwig “Palladium-Catalyzed Amination of Aryl Halides and Sulfonates” in Modern Arene Chemistry. Edited by Didier Astruc, Wiley-VCH Weinheim 2002, pp. 107-168.
Horchler, C. L. et. al “Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: A late-stage diversification approach to potent 5HT1B antagonists” Bioorganic & Medicinal Chemistry 2007, 15, 939-950.
Batey, et. al. “Carbamoyl-Substituted N-Heterocyclic Carbene Complexes of Palladium(II): Application to Sonogashira Cross-Coupling Reactions” Organic Letters 2002, 4, 1411-1414.
Dudash et. al. “Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors” Bioorganic & Medicinal Chemistry Letters 2005, 15, 4790-4793.
Borisy et. al. “Systematic discovery of multicomponent therapeutics” PNAS 2003, 100, 7977-7982.
Grant R. Zimmermann “Multi-target therapeutics: when the whole is greater than the sum of the parts.” Drug Discovery Today 2007, 12, 34-42.
Martin, Yvonne C. et. al. “Do Structurally Similar Molecules Have Similar Biological Activity?” Journal of Medicinal Chemistry 2002, 45, 4350-4358.
Yue H. Li “Synthesis and structure—activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase” Bioorganic & Medicinal Chemistry Letters 2006, 16, 5892-5896.
Asakawa, A., et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Research, 2001, vol. 33(9), pp. 554-558.
Drueckes P et al., Photometric Microtiter Assay of Inorganic Phosphate in the Presence of Acid-Labile Organic Phosphates, Anal. Biochem, 1995, vol. 230(1), pp. 173-177.
Engers H.D. et al., Kinetic Mechanism Of Phosphorylase a. I. Initial Velocity Studies, Journal Of Biochemistry, (1970), vol. 48, pp. 746-754.
Lee Daniel W. et al., Leptin Agonists as a Potential Approach to the Treatment of Obesity, Drugs of the Future, (2001), vol. 26, No. 9, pp. 873-881.
Link, et al., Derivatives of 3-Quinolinecarboxylic Acid with Oxygen Substitution in Position 4,5 and 8: Synthesis, Reactions, NMR.-Studien, Helvetica Chimica Acta (1982) vol. 65, Fasc.8 pp. 2645-2667.
Salvador Javier et al., Perspectives in the Therapeutic Use of Leptin, Expert Opinion Pharmacotherapy, (2001), vol. 2, No. 10, pp. 1615-1622.
Tyle, Praveen, Iontophoretic Devices for Drug Delivery, Pharmaceutical Research, vol. 3, No. 6, 1986, pp. 318-326.
Wolfe, et. al., Rational Developement of Practical Catalysts for Aromatic Carbon-Nitrogen Bond Formation, Acc. Chem. Res. (1998) vol. 31 pp. 805-818.
Zunft, H. et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in Therapy, 2001, vol. 18(5), pp. 230-236.
Defossa Elisabeth
Herling Andreas
Kadereit Dieter
Klabunde Thomas
Ruf Sven
Desai Rita J
Kurys Barbara E
O'Dell David K
Sanofi-Aventis Deutschland GmbH
LandOfFree
Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024503